DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue
- PMID: 40437235
- DOI: 10.1038/s41418-025-01530-7
DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue
Abstract
Formation of cytoplasmic inclusions (CIs) of TDP-43 and FUS, along with DNA damage accumulation, is a hallmark of affected motor neurons in Amyotrophic Lateral Sclerosis (ALS). However, the impact of CIs on DNA damage response (DDR) and repair in this pathology remains unprobed. Here, we show that CIs of TDP-43 and FUSP525L, co-localizing with stress granules, lead to a dysfunctional DDR activation associated with physical DNA breakage. Inhibition of the activity of the DDR kinase ATM, but not of ATR, abolishes DDR signaling, indicating that DNA double-strand breaks (DSBs) are the primary source of DDR activation. In addition, cells with TDP-43 and FUSP525L CIs exhibit reduced DNA damage-induced RNA synthesis at DSBs. We previously showed that the two endoribonucleases DROSHA and DICER, also known to interact with TDP-43 and FUS during small RNA processing, contribute to DDR signaling at DSBs. Treatment with enoxacin, which stimulates DDR and repair by boosting the enzymatic activity of DICER, restores a proficient DDR and reduces DNA damage accumulation in cultured cells with CIs and in vivo in a murine model of ALS. In Drosophila melanogaster, Dicer-2 overexpression rescues TDP-43-mediated retinal degeneration. In summary, our results indicate that the harmful effects caused by TDP-43 and FUS CIs include genotoxic stress and that the pharmacological stimulation of the DNA damage signaling and repair counteracts it.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethical approval: Mice used in this study were housed at the Tor Vergata University Animal Facility (CIMETA) in accordance with the FELASA Recommendations, European Guidelines for the use of animals in research (2010/63/EU), and Italian Laws (D.L. 26/2014). All experiments were conducted in compliance with the ARRIVE guidelines, with the approval by the local ethics committee and the Italian Ministry of Health.
References
-
- Farina S, Esposito F, Battistoni M, Biamonti G, Francia S. Post-translational modifications modulate proteinopathies of TDP-43, FUS and hnRNP-A/B in amyotrophic lateral sclerosis. Front Mol Biosci. 2021;8:585. - DOI
-
- Chen S, Sayana P, Zhang X, Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 2013;8:1–15. - DOI
-
- Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010;19:46–64. - DOI
Grants and funding
- RIPREI2023_7c8ae10d783c/Istituto Superiore di Sanità (ISS)
- PRIN 2020 CXFL4T/Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)
- MNESYS (PE0000006)/Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)
- CN00000041 CN3 RNA/Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)
- PNRR-CN3/Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)
- 2021 DDR&ALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- 2016 DDRNA&ALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- SwitchALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- SwitchALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- 2021 DDR&ALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- 2016 DDRNA&ALS/Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica (Italian Research Foundation for ALS)
- DBA.AD005.225-NUTRAGE-FOE2021/Consiglio Nazionale delle Ricerche (National Research Council)
- DBA.AD005.225-NUTRAGE-FOE2021/Consiglio Nazionale delle Ricerche (National Research Council)
- Flagship Project Interomics/Consiglio Nazionale delle Ricerche (National Research Council)
- TELORNAGING-835103/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
- AIRC-IG(21762)/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- AIRC 5×1000/Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research)
- GGP17111/Fondazione Telethon (Telethon Foundation)
- POR FESR 2014-2020/Regione Lombardia (Region of Lombardy)
- Ricerca Corrente 2022 - 2024/Ministero della Salute (Ministry of Health, Italy)
- Ricerca Corrente 2022 - 2024/Ministero della Salute (Ministry of Health, Italy)
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
